BIOVIEW SUBMITS BREAST CANCER DIAGNOSIS SYSTEM TO FDA

BioView Ltd., which develops, manufactures and supplies cell imaging equipment, biological kits and software, has filed an application for US Food and Drug Administration (FDA) approval to market its breast cancer early diagnosis system. The company has already begun marketing automated diagnosis systems for bladder cancer, leukemia and amniotic fluid testing in Europe and the US.
Globes Online